NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 11, 2026 — Creative Biolabs expands functionalized lipid-based delivery systems, offering customized targeted liposomes, ROS-responsive, and hypoxia-responsive platforms for research.
September 11, 2026 — Teen drunk driver crashes into tree in Ramapo, injuring two. Learn about victims' rights, compensation, and why timely legal action matters in New York.
September 10, 2026 — Dental Design Studios expands to nine Valley locations, offering cosmetic dentistry, dental implants, and same-day emergency care in Chandler and Phoenix. Learn more.
September 10, 2026 — SS Innovations reports 79% growth in SSi Mantra robotic surgeries, with 14,103 procedures and 238 systems installed across 12 countries. FDA and CE milestones ahead.
September 10, 2026 — VERAXA Biotech names Dr. Christoph Erkel as CSO to lead BiTAC® oncology pipeline. Recent Paul-Ehrlich-Institute advice and AACR data support clinical advancement.
September 10, 2026 — Earth Science Tech (OTC: ETST) reports FY2026 revenue of $35.7M, positive operating cash flow, and a stronger balance sheet with no long-term debt. Learn more.
September 10, 2026 — SS Innovations launches Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 system. Read more on Nasdaq: SSII.
September 10, 2026 — Quantum BioPharma advances Lucid-MS to phase 2 MS trial after FDA IND clearance. First-in-class PAD2 inhibitor could transform multiple sclerosis treatment.
September 10, 2026 — Quantum BioPharma receives FDA clearance for Phase 2 trial of Lucid-MS, a first-in-class myelin repair therapy for progressive MS. A potential game-changer.
September 10, 2026 — Quantum BioPharma gets FDA clearance for Phase 2 trial of Lucid-MS, a first-in-class MS drug targeting myelin repair, potentially transforming treatment.
September 10, 2026 — SS Innovations' SSi Mantra surgical robot reaches 14,103 procedures, 238 systems installed globally. FDA and CE mark decisions pending.
September 10, 2026 — Helus Pharma CEO Michael Halstead to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. Learn about the company's novel serotonergic agonists for depression and anxiety.
September 10, 2026 — Onco-Innovations CMO Dr. Islam Mohamed discusses ONC010, a novel PNKP inhibitor with dual selectivity, and its promising preclinical results in cancer treatment.
September 10, 2026 — Quantum BioPharma's Lucid-MS advances to phase 2 MS trial after FDA IND clearance. Novel PAD2 inhibitor targets demyelination directly. Read more.
September 10, 2026 — GeoVax Labs appeals Nasdaq delisting, reaffirms focus on GEO-MVA vaccine and Gedeptin® cancer therapy. Hearing set for October 13, 2026.
September 10, 2026 — American Heart Association's PREVENT equations integrated into Epic EHR, enabling nationwide cardiovascular risk assessment and personalized prevention in routine care.
September 10, 2026 — BioCorRx appoints Richard J. Baum, former Acting Director of White House ONDCP, to Strategic Advisory Board to advance addiction treatment and policy strategies.
September 10, 2026 — Dr. Wael Sakr Scholarship for Medical Students offers $1,000 to pre-med undergrads. Apply by April 15, 2027. Essay required. Winner announced May 15, 2027.
September 10, 2026 — Get MRI Now expands its rapid MRI referral service to nine new states, offering physician-authorized referrals in seconds for a flat $49.95 fee. Available in FL, TX, NV, CA, AZ, NM, IL, CO, NY, NJ.
September 10, 2026 — Fisher House SoCal releases a donor guide to help you choose the best military charity. Learn to evaluate transparency, impact, and support for veterans' families.